학술논문
P.92 UMINESCE: Phase 3 study of satralizumab, a therapeutic recycling antibody targeting the IL-6 receptor, in patients with generalised myasthenia gravis
Document Type
Abstract
Author
Source
In Neuromuscular Disorders October 2022 32 Supplement 1:S80-S81
Subject
Language
ISSN
0960-8966